Brookstone Capital Management Has $12.54 Million Stock Holdings in Colgate-Palmolive Company $CL

Brookstone Capital Management raised its stake in Colgate-Palmolive Company (NYSE:CL) by 11.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 158,730 shares of the company’s stock after purchasing an additional 15,842 shares during the period. Brookstone Capital Management’s holdings in Colgate-Palmolive were worth $12,543,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Copia Wealth Management acquired a new position in Colgate-Palmolive during the 3rd quarter worth approximately $29,000. Cloud Capital Management LLC acquired a new stake in Colgate-Palmolive in the third quarter valued at approximately $30,000. Global Wealth Strategies & Associates increased its holdings in shares of Colgate-Palmolive by 300.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after acquiring an additional 300 shares in the last quarter. Grove Bank & Trust increased its holdings in shares of Colgate-Palmolive by 182.6% during the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after acquiring an additional 263 shares in the last quarter. Finally, Kelleher Financial Advisors acquired a new position in shares of Colgate-Palmolive during the third quarter worth approximately $35,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.5%

NYSE:CL opened at $85.31 on Wednesday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The firm has a 50-day moving average price of $91.13 and a two-hundred day moving average price of $83.40. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The firm has a market cap of $68.44 billion, a price-to-earnings ratio of 32.56, a price-to-earnings-growth ratio of 3.84 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same period in the prior year, the company posted $0.91 earnings per share. Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. On average, equities analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 80.92%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 184,683 shares of company stock valued at $17,486,693 over the last quarter. Corporate insiders own 0.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the subject of several research reports. Argus reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Colgate-Palmolive in a research note on Friday, February 20th. TD Cowen reissued a “hold” rating and set a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday. UBS Group upped their target price on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Finally, Evercore lifted their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average price target of $95.19.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.